Nano Dimension Ltd - ADR vs Nuwellis Inc — how do they compare? Nano Dimension Ltd - ADR trades at $1.49 (market cap $322.08M), while Nuwellis Inc trades at $2.94 (market cap $1.09M). The key difference: Nano Dimension Ltd - ADR is far larger — about 295.5× Nuwellis Inc's market cap, and Nano Dimension Ltd - ADR is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals.
| NNDM | NUWE | |
|---|---|---|
Market Cap | $322.08M | $1.09M |
Sector | Technology | Technology |
52-Week High | $2.14 | $527.46 |
52-Week Low | $1.21 | $2.80 |
Enterprise Value | -$87.26M | -$722.58K |
Signals from Pluang's Aura AI — not financial advice
Nano Dimension (NNDM) trades at $1.49, down 3.87% on the day, with a bullish technical signal from moving averages. The company reported revenue of $102.44 million in 2025 but a net loss of $293.30 million, reflecting a negative net income margin of 286.72%. Recent news highlights board changes, cost-saving initiatives, and a proposed business combination with Infinite Epigenetics.
The outlook remains challenging due to persistent losses and negative cash flow, though cost reductions and strategic moves aim to stabilize. Key risks include execution of the turnaround plan and shareholder disputes. Analyst sentiment is mixed, with the stock trading below book value, indicating potential value if operations improve.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →